Bruce J Dezube Selected Research

Kaposi Sarcoma (Kaposi's Sarcoma)

2/2014	Phase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042.
4/2012	Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study.
10/2011	Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi's sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial.
2/2011	Antimicrobial and non-antimicrobial tetracyclines in human cancer trials.
8/2010	Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy.
12/2009	Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic Acid.
9/2009	Studying Rac1-induced tumorigenesis suggests antioxidants may help prevent and treat Kaposi's sarcoma.
6/2009	Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma.
5/2009	Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood.
4/2009	Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruce J Dezube Research Topics

Disease

51	Neoplasms (Cancer) 01/2022 - 01/2002
32	Acquired Immunodeficiency Syndrome (AIDS) 01/2016 - 01/2002
30	Kaposi Sarcoma (Kaposi's Sarcoma) 02/2014 - 01/2002
7	Infections 02/2014 - 08/2002
7	HIV Infections (HIV Infection) 11/2012 - 11/2004
6	Neoplasm Metastasis (Metastasis) 01/2014 - 01/2002
5	Carcinoma (Carcinomatosis) 08/2019 - 08/2006
5	Lymphoma (Lymphomas) 01/2016 - 10/2007
4	Viremia 05/2009 - 11/2006
3	Disease Progression 01/2022 - 11/2006
3	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2007
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 08/2011
3	Melanoma (Melanoma, Malignant) 01/2016 - 01/2014
3	Primary Effusion Lymphoma 06/2012 - 12/2002
3	Gynecomastia 08/2010 - 11/2002
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2010 - 11/2004
3	Carcinogenesis 09/2009 - 12/2006
2	Triple Negative Breast Neoplasms 08/2019 - 08/2019
2	Febrile Neutropenia 01/2019 - 01/2016
2	Thrombocytopenia (Thrombopenia) 01/2019 - 01/2016
2	Hyperbilirubinemia 02/2016 - 01/2016
2	Multiple Myeloma 01/2016 - 07/2004
2	Renal Cell Carcinoma (Grawitz Tumor) 04/2015 - 01/2014
2	Neutropenia 04/2014 - 01/2007
2	AIDS-related Kaposi sarcoma 01/2011 - 09/2004
2	Lung Neoplasms (Lung Cancer) 11/2010 - 10/2010
2	Pain (Aches) 08/2010 - 03/2008
2	Diarrhea 02/2005 - 12/2004
1	Muscle Cramp (Cramp) 01/2016
1	Plasmablastic Lymphoma 01/2016
1	Hypophosphatemia 01/2016
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2015
1	Keratoacanthoma 04/2015
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2015
1	Hand-Foot Syndrome 04/2014
1	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 01/2013
1	Inflammation (Inflammations) 06/2012

Drug/Important Bio-Agent (IBA)

8	EnzymesIBA 01/2019 - 02/2011
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 04/2002
6	pevonedistatIBA 01/2019 - 05/2015
6	Matrix Metalloproteinases (MMPs)IBA 02/2011 - 01/2002
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2005
5	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2019 - 05/2015
5	liposomal doxorubicin (Doxil)FDA Link 01/2013 - 04/2002
5	Rituximab (Mabthera)FDA Link 01/2013 - 06/2008
4	niraparibIBA 01/2022 - 08/2019
4	Pharmaceutical PreparationsIBA 01/2019 - 02/2002
4	Monoclonal AntibodiesIBA 04/2015 - 06/2008
4	Imatinib Mesylate (Gleevec)FDA Link 01/2015 - 02/2005
4	tetracycline CMT-3IBA 02/2011 - 01/2002
4	Angiogenesis InhibitorsIBA 01/2011 - 01/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2002
3	pembrolizumabIBA 01/2020 - 08/2019
3	Platelet-Derived Growth FactorIBA 02/2014 - 02/2005
3	Proteins (Proteins, Gene)FDA Link 11/2006 - 12/2002
2	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2019
2	Bevacizumab (Avastin)FDA Link 01/2022 - 08/2019
2	Poly Adenosine Diphosphate RiboseIBA 08/2019 - 08/2019
2	fresolimumabIBA 04/2015 - 01/2014
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2014 - 12/2006
2	AntioxidantsIBA 06/2012 - 09/2009
2	Protease Inhibitors (Protease Inhibitor)IBA 10/2011 - 11/2002
2	Cytotoxins (Cytolysins)IBA 10/2011 - 08/2010
2	1-dodecylpyridoxal (PLD)IBA 08/2010 - 03/2008
2	MicroRNAs (MicroRNA)IBA 06/2009 - 04/2009
2	Viral DNAIBA 05/2009 - 08/2002
2	Interleukin-6 (Interleukin 6)IBA 04/2007 - 09/2006
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2007 - 09/2006
2	ChemokinesIBA 09/2006 - 05/2004
2	Matrix Metalloproteinase InhibitorsIBA 03/2006 - 01/2002
2	RNA (Ribonucleic Acid)IBA 05/2004 - 02/2002
2	Alitretinoin FDA Link 04/2002 - 02/2002
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	dostarlimabIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2019
1	PlatinumIBA 08/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	Gemcitabine FDA Link 01/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2016
1	Ligases (Synthetase)IBA 02/2016
1	Cullin Proteins (Cullins)IBA 02/2016
1	CreatinineIBA 01/2016
1	antineoplaston A10 (A 10)IBA 01/2016
1	Transaminases (Aminotransferases)IBA 01/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2015
1	Rifabutin (Ansamycin)FDA Link 01/2015
1	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 01/2015
1	Sunitinib (Sutent)FDA Link 04/2014
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013
1	Prednisone (Sone)FDA LinkGeneric 01/2013
1	Vincristine (Oncovin)FDA LinkGeneric 01/2013
1	TriterpenesIBA 06/2012
1	Phosphotransferases (Kinase)IBA 06/2012

Therapy/Procedure

29	Therapeutics 01/2022 - 02/2002
25	Highly Active Antiretroviral Therapy (HAART) 01/2016 - 12/2003
18	Drug Therapy (Chemotherapy) 01/2022 - 01/2004